Clinical Research Directory
Browse clinical research sites, groups, and studies.
Immunoadsorption Versus Plasma Exchange for Treatment of Guillain-Barré Syndrome (GBS)
Sponsor: University of Ulm
Summary
This is an observations study evaluating safety and efficacy of immunoadsorption compared to plasma exchange in Guillain-Barré Syndrome.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
20
Start Date
2021-04-28
Completion Date
2025-05-04
Last Updated
2024-05-08
Healthy Volunteers
No
Conditions
Interventions
Immunoadsorption
1 cycle, consisting of 5 sessions on 5 consecutive days with processing of the 0.7-fold individual plasma volume (maximum 2.5 l) each days with tryptophan adsorbers.
Plasma Exchange
1 cycle, consisting of 5 sessions on 5 consecutive days with exchange of 0.7-fold plasma volume (maximum 2.5 l) each day with albumin solution as volume replacement solution.
Locations (1)
Department of Neurology, University of Ulm
Ulm, Baden-Wurttemberg, Germany